229 related articles for article (PubMed ID: 24728159)
1. Challenges and pitfalls in the diagnosis of hyperprolactinemia.
Vilar L; Fleseriu M; Bronstein MD
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):9-22. PubMed ID: 24728159
[TBL] [Abstract][Full Text] [Related]
2. Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia.
Vilar L; Vilar CF; Lyra R; Freitas MDC
Neuroendocrinology; 2019; 109(1):7-19. PubMed ID: 30889571
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic evaluation of hyperprolactinemia.
Biller BM
J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
[TBL] [Abstract][Full Text] [Related]
5. [Misleading diagnosis of hyperprolactinemia in women].
Paepegaey AC; Veron L; Wimmer MC; Christin-Maitre S
Gynecol Obstet Fertil; 2016 Mar; 44(3):181-6. PubMed ID: 26966035
[TBL] [Abstract][Full Text] [Related]
6. Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
Vilar L; Abucham J; Albuquerque JL; Araujo LA; Azevedo MF; Boguszewski CL; Casulari LA; Cunha Neto MBC; Czepielewski MA; Duarte FHG; Faria MDS; Gadelha MR; Garmes HM; Glezer A; Gurgel MH; Jallad RS; Martins M; Miranda PAC; Montenegro RM; Musolino NRC; Naves LA; Ribeiro-Oliveira Júnior A; Silva CMS; Viecceli C; Bronstein MD
Arch Endocrinol Metab; 2018; 62(2):236-263. PubMed ID: 29768629
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].
Vilar L; Moura E; Canadas V; Gusmão A; Campos R; Leal E; Teixeira L; Santos V; Gomes B; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Azevedo M; Casulari LA; Naves LA
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):86-91. PubMed ID: 17435860
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed.
Tamer G; Telci A; Mert M; Uzum AK; Aral F; Tanakol R; Yarman S; Boztepe H; Colak N; Alagöl F
Endocrine; 2012 Feb; 41(1):138-43. PubMed ID: 21959531
[TBL] [Abstract][Full Text] [Related]
9. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
[TBL] [Abstract][Full Text] [Related]
10. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
[TBL] [Abstract][Full Text] [Related]
11. [Hyperprolactinemia unrelated to prolactinoma].
Krysiak R; Okopień B
Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
[TBL] [Abstract][Full Text] [Related]
12. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
[TBL] [Abstract][Full Text] [Related]
13. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
Bağdatoğlu C; Bağdatoğlu OT; Muslu N; Köseoğlu A; Dağtekin A; Polat G; Dolgun H; Karataş MA
Turk Neurosurg; 2008 Jul; 18(3):223-7. PubMed ID: 18814107
[TBL] [Abstract][Full Text] [Related]
14. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
Lu CC; Hsieh CJ
Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
[TBL] [Abstract][Full Text] [Related]
15. [Current diagnosis and treatment of hyperprolactinemia].
Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
[TBL] [Abstract][Full Text] [Related]
16. Etiological diagnosis of hyperprolactinemia.
Cortet-Rudelli C; Sapin R; Bonneville JF; Brue T
Ann Endocrinol (Paris); 2007 Jun; 68(2-3):98-105. PubMed ID: 17524347
[TBL] [Abstract][Full Text] [Related]
17. Macroprolactinemia: new insights in hyperprolactinemia.
Kasum M; Oreskovic S; Zec I; Jezek D; Tomic V; Gall V; Adzic G
Biochem Med (Zagreb); 2012; 22(2):171-9. PubMed ID: 22838183
[TBL] [Abstract][Full Text] [Related]
18. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
[TBL] [Abstract][Full Text] [Related]
19. Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.
Zaidi HA; Cote DJ; Castlen JP; Burke WT; Liu YH; Smith TR; Laws ER
World Neurosurg; 2017 Jan; 97():2-7. PubMed ID: 27671881
[TBL] [Abstract][Full Text] [Related]
20. Macroprolactinemia: a new cause of hyperprolactinemia.
Hattori N
J Pharmacol Sci; 2003 Jul; 92(3):171-7. PubMed ID: 12890882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
